Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBMX pseudogene 3 is a *processed pseudogene* derived from the parental gene *RNA binding motif protein, X-linked* (RBMX). Pseudogenes are DNA sequences that resemble functional genes but typically do not produce functional proteins. Although transcribed pseudogenes can sometimes regulate their parental gene or related genes at the RNA level, there is no published evidence that RBMXP3 is functional or relevant in disease or therapy. Pseudogenes as a class have been studied for potential regulatory roles, such as competing for microRNAs or RNA-binding proteins, but most do not function as classical drug targets nor are they implicated directly in major disease mechanisms[2]. RBMXP3 is not a suitable or actionable therapeutic target[2][3]. If you are seeking information about the functional, therapeutic, or disease relevance of the *RBMX* gene/protein itself (not the pseudogene), refer to "RNA binding motif protein, X-linked" (RBMX), which is a nuclear RNA-binding protein involved in splicing regulation, DNA repair, genomic stability, and may play roles in cancers and intellectual disability syndromes[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RBMX pseudogene 3 (RBMXP3).